Spero Therapeutics, Inc. (SPRO) financial statements (2022 and earlier)

Company profile

Business Address 675 MASSACHUSETTS AVENUE
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments146,402126,90682,045115,44387,288
Cash and cash equivalents112,58485,20929,73034,08087,288
Short-term investments33,81841,69752,31581,363 
Deferred costs   316 
Other undisclosed current assets11,47012,23913,3698,4604,771
Total current assets:157,872139,14595,414124,21992,059
Noncurrent Assets
Operating lease, right-of-use asset6,5307,1144,875
Property, plant and equipment1,0261,6692,2732,8931,164
Deposits noncurrent assets   153206
Restricted cash and investments    50
Other noncurrent assets5,6445,2123,5201,192 
Other undisclosed noncurrent assets 31121549 
Total noncurrent assets:13,20014,30610,6894,7871,420
TOTAL ASSETS:171,072153,451106,103129,00693,479
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,1366,3617,9897,3256,021
Accounts payable1,1011,1554,1473,6033,470
Accrued liabilities2,1511,2881,2121,3431,182
Employee-related liabilities5,8843,9182,6302,3791,369
Deferred revenue1,857  
Debt  928  
Deferred rent credit   229
Derivative instruments and hedges, liabilities   223223
Deferred revenue and credits143
Other undisclosed current liabilities7,6777,98217,7464,5411,770
Total current liabilities:18,67014,34326,66312,3188,157
Noncurrent Liabilities
Long-term debt and lease obligation6,1117,0684,866  
Long-term debt, excluding current maturities138177249  
Operating lease, liability5,9736,8914,617
Liabilities, other than long-term debt8,786  833365
Deferred revenue and credits365
Deferred revenue8,786  
Deferred rent credit   833
Other undisclosed noncurrent liabilities49,216(6,891)   
Total noncurrent liabilities:64,1137,0684,866833365
Total liabilities:82,78321,41131,52913,1518,522
Stockholders' equity
Stockholders' equity attributable to parent88,289132,04074,574115,50084,602
Preferred stock33   
Common stock3229191714
Additional paid in capital455,719409,722273,966254,013181,428
Accumulated other comprehensive income (loss)(2)(7)16(28) 
Accumulated deficit(367,463)(277,707)(199,427)(138,502)(96,840)
Stockholders' equity attributable to noncontrolling interest   355355
Total stockholders' equity:88,289132,04074,574115,85584,957
TOTAL LIABILITIES AND EQUITY:171,072153,451106,103129,00693,479

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues18,2569,33018,1473,9661,979
Revenue, net1,979
Gross profit:18,2569,33018,1473,9661,979
Operating expenses(106,227)(88,443)(81,363)(46,772)(43,709)
Operating loss:(87,971)(79,113)(63,216)(42,806)(41,730)
Nonoperating income (expense)(1,785)8332,2917711,761
Investment income, nonoperating3464011,328  
Foreign currency transaction loss, before tax   (373)(83)
Other nonoperating income (expense)(395)4327401,1441,844
Other undisclosed income from continuing operations before equity method investments, income taxes   37383
Net loss:(89,756)(78,280)(60,925)(41,662)(39,886)
Net income attributable to noncontrolling interest    1,143
Other undisclosed net income (loss) attributable to parent(44)(20)25  
Net loss attributable to parent:(89,800)(78,300)(60,900)(41,662)(38,743)
Preferred stock dividends and other adjustments (549)  (6,146)
Other undisclosed net income (loss) available to common stockholders, basic4420  (1,208)
Net loss available to common stockholders, diluted:(89,756)(78,829)(60,900)(41,662)(46,097)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(89,756)(78,280)(60,925)(41,662)(39,886)
Other comprehensive loss   (28) 
Comprehensive loss:(89,756)(78,280)(60,925)(41,690)(39,886)
Comprehensive income, net of tax, attributable to noncontrolling interest    1,143
Other undisclosed comprehensive income (loss), net of tax, attributable to parent5(23)44  
Comprehensive loss, net of tax, attributable to parent:(89,751)(78,303)(60,881)(41,690)(38,743)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: